Literature DB >> 9220238

Indications for penetrating keratoplasty in Canada, 1986-1995.

E Liu1, A R Slomovic.   

Abstract

PURPOSE: To examine the leading indications for penetrating keratoplasty.
METHODS: We retrospectively performed a chart review of 904 cases of penetrating keratoplasty over a 10-year period (1986-1995). Where possible, the clinical indication was corroborated by the pathological report.
RESULTS: Leading indications included pseudophakic bullous keratopathy (PBK; 28.5%), regraft (22.4%), keratoconus (10.0%), Fuchs' dystrophy (7.6%), aphakic bullous keratopathy (ABK; 6.1%), herpetic keratopathy (4.2%), bacterial infection (4.2%), physical trauma (4%), interstitial keratitis (3.7%), and corneal scarring (2.8%). The most common type of intraocular lens found in patients with PBK was the anterior-chamber lens [AC IOL, 71.6%; posterior-chamber lens (PC IOL), 16%; iris-plane IOL (IP IOL; 12.5%]. In our series, we noted decreasing trends in the incidences of ABK (p < 0.001) and PBK (p < 0.04) and an increasing trend in the incidence of regraft (p < 0.0083). Our data do not show statistically significant changes in the incidences of Fuchs' dystrophy and keratoconus. Gender differences were present for Fuchs' dystrophy with female exceeding male patients by a 3:1 ratio (p < 0.001). Male exceeded female patients by 2:1 for keratoconus (p < 0.001). Male exceeded female patients by 3:1 for trauma (p < 0.001).
CONCLUSIONS: In this series, the leading indications for penetrating keratoplasty were found to be generally in agreement with the data reported in recent literature. Variations may reflect the wide variations in practice and referral patterns.

Entities:  

Mesh:

Year:  1997        PMID: 9220238

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  21 in total

1.  Ophthaproblem. Pseudophakic bullous keratopathy.

Authors:  J Cheung; S Sharma
Journal:  Can Fam Physician       Date:  2000-06       Impact factor: 3.275

2.  Penetrating keratoplasty: indications over a 10 year period.

Authors:  N Al-Yousuf; I Mavrikakis; E Mavrikakis; S M Daya
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

3.  Repeat penetrating keratoplasty: indications, graft survival, and visual outcome.

Authors:  H Al-Mezaine; M D Wagoner
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  Longitudinal study of keratoconus progression.

Authors:  Xiaohui Li; Huiying Yang; Yaron S Rabinowitz
Journal:  Exp Eye Res       Date:  2007-07-06       Impact factor: 3.467

5.  Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 Glycocalyx.

Authors:  Ben J Glasgow; Oktay K Gasymov; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

6.  Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register.

Authors:  M Claesson; W J Armitage; P Fagerholm; U Stenevi
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

7.  Analysis of causes of bullous keratopathy in East China: a 10-year retrospective study.

Authors:  Xin Wang; Wentao Wang; Jianjiang Xu; Yan Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-08       Impact factor: 3.117

8.  Fuchs' corneal dystrophy.

Authors:  Allen O Eghrari; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2010-04

9.  Indications for and techniques of keratoplasty at Vietnam National Institute of Ophthalmology.

Authors:  Pham Ngoc Dong; Truong Nhu Han; Anthony J Aldave; Hoang Thi Minh Chau
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

10.  Tear lipocalin captures exogenous lipid from abnormal corneal surfaces.

Authors:  Ben J Glasgow; Oktay K Gasymov; Adil R Abduragimov; Jamison J Engle; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.